US medtech will weather this storm: battered but not tattered
This article was originally published in Clinica
The US medtech industry has fared better than most other industries in the storm that is the global economic recession. But it was not entirely immune, Ernst & Young analysts point out in a report released at the AdvaMed 2009 conference today.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.